Pharmaceutical Industry in
Lugano
75 companies in Pharmaceutical Industry based in Lugano — name and year of registration from the commercial register.
50 of 75 companies
Kamfarma SA
Since 1978 · 11–20 empl.
The core activity of Kamfarma is the development and manufacturing of pharmaceutical active ingredients (APIs) and finished dosage forms (FDFs) in cooperation with global marketing partners. The company specializes in the development of complex generics and innovative medicines, particularly in the areas of oncology and specialized medicines. Kamfarma offers services such as API development, manufacturing and project management, as well as the development of finished dosage forms in various formulations. In addition, the company supports its partners in the clinical development, registration and marketing of medicines in various territories.
Fordras SA
Since 1983 · 101–500 empl.
The company's core activity is the development, production and marketing of natural proteins and enzymes for the food, pharmaceutical and feed industries. The company focuses particularly on the production of highly concentrated, active ingredients for industrial applications, such as lysozymes, and offers solutions for food processing and preservation as well as for the health and nutrition industry.
Chemo Project SA
Since 1984 · 21–50 empl.
The core activity of Insud Pharma is the development, manufacture and marketing of pharmaceutical products. The company operates in the healthcare sector and offers innovative solutions for healthcare. The core activities include research and development (15 research and development centers), production (20 industrial facilities) and distribution of medicines.
Altergon SA
Since 1985 · 1–10 empl.
The core activity of Altergon Italia Srl Unipersonale is the development, manufacture and marketing of pharmaceutical products and medical devices, particularly: * Production of medicated plasters (cerotti medicati) and transdermal patches (patch transdermici) * Production of hydrogel products for topical and transdermal application of active ingredients * Production of hyaluronic acid products (Acido Ialuronico) for the pharmaceutical and medical industry * Development and production of biotechnological products, such as biopolymers for orthopedics and tissue engineering * Production of medical devices, such as pre-filled syringes and infusion solutions * Development and production of innovative products, such as microneedles for transdermal application of active ingredients The company also offers services such as Contract Development and Manufacturing (CDMO), where it takes over the development and production of pharmaceutical products for other companies.
Refarmed Chemicals SA
Since 1995 · 21–50 empl.
The core activity of Refarmed Chemicals Ltd. is the distribution of pharmaceutical active ingredients (Active Pharmaceutical Ingredients, API) and finished dosage forms (Finished Dosage Form, FDF) for the generic pharmaceutical industry.
NANONICA SA
Since 2006 · 1–10 empl.
NANONICA SA is a firm focused on knowledge transfer and commercialization of academic research in nanotechnology and microtechnology. It provides advisory services to identify projects and expertise, and supports development and market introduction of technologies across medicine, energy and environmental science.
CHEMO AG, Vienna, Lugano Branch
Since 2006 · 1–10 empl.
The core activity of Chemo is the development, manufacture and marketing of pharmaceutical products, including: Active Pharmaceutical Ingredients (APIs), Finished Dosage Forms (FDFs) for human and veterinary use, Over-the-counter (OTC) products, and Dietary supplements and medical devices. The company also offers Contract Manufacturing (CMO) services and has a global presence with 15 manufacturing sites and 200 scientists and researchers.
CoreQuest Sagl
Since 2008 · 1–10 empl.
CoreQuest Sagl is a pharmaceutical company conducting research and development of pharmaceutical products and medical devices in nephrology and surgical areas. It develops biocompatible hypertonic solutions for peritoneal dialysis, designs devices and monitoring techniques for dialysis patients, and pursues research programs addressing chronic renal failure and congestive heart failure, including a peritoneal ultrafiltration platform (Polycore).
Swiss Applied Coating Research (S.A.C.R.) GmbH
Since 2011 · 1–10 empl.
The core activity of Swiss A.C.R. Applied Coating Research is the development and production of film coating solutions for the pharmaceutical, nutraceutical and food industries, with a particular focus on natural polymers. The company offers specialized services such as the development of Solid Oral Dosage Forms, Colon-Delivery and Sustained-Release systems, as well as the provision of natural functional polymers for coatings.
MABXIENCE SA
Since 2012 · 101–500 empl.
The company's core activity is the development, manufacture and marketing of biopharmaceutical products, including active pharmaceutical ingredients (APIs), vaccines and finished dosage forms (FDFs), as well as the production of biotechnological medicines for the manufacture of monoclonal antibodies and vaccines.
ADIENNE SA
Since 2012 · 21–50 empl.
ADIENNE SA is an integrated biopharmaceutical group focused on research, development and manufacturing of medicines for rare and severe hematological and immunological diseases. The company provides GMP development and manufacturing services, including lyophilization of cytotoxic finished products in ready-to-use systems (e.g., Multichamber Flexible Bag, FillChoice), and markets products such as TEPADINA® and PHELINUN®.
Cures Healthcare Ltd
Since 2012 · 11–20 empl.
The core activity of Cures Health Care is the development, manufacture and export of pharmaceutical products, particularly generics and biosimilars, of both Swiss and non-Swiss origin. The company offers a wide range of medications, including tablets, capsules and injectable products, used to treat various diseases and conditions, such as hypertension, diabetes, anxiety disorders and cancer. Cures Health Care operates in over 12 countries worldwide, including the MENA region, Europe, the US and Canada, and collaborates with local licensees and government authorities to offer its products on the respective markets.
Seegpharm SA
Since 2012 · 1–10 empl.
Seegpharm SA develops and out-licenses complex generic pharmaceuticals through product co‑development. The company outsources development work including API synthesis‑route development and finished‑dosage‑form development, manages patent freedom‑to‑operate analyses and regulatory registrations, and undertakes selected promotion and distribution activities.
Fondazione Ceschina
Since 2013 · 1–10 empl.
The core activity of Sanitaria Ceschina & C. (S.p.A.) is the manufacture and distribution of medical products, particularly aseptic and antiseptic medications as well as health equipment.
H.E. ADVANCED NUTRITION SA
Since 2013 · 11–20 empl.
The core activity of HE Advanced Nutrition SA is the research and production of nutraceutical and pharmaceutical products, particularly food supplements and medicines, with innovative formulations and the highest quality standards.
ADIENNE Pharma & Biotech SA
Since 2013 · 101–500 empl.
ADIENNE Pharma & Biotech SA is an integrated biopharmaceutical group that develops medicinal products and provides pharmaceutical and biotech manufacturing services. The company focuses on rare hematological and immunological diseases, maintains a portfolio of orphan-designated, marketed, clinical and preclinical product candidates, offers lyophilization for cytotoxic products in ready-to-use systems, and its lead clinical candidate is BEGELOMAB.
GT Gain Therapeutics SA
Since 2017 · 11–20 empl.
The company is active in the field of biopharmaceuticals (bio-pharma).
PROBIONOVA SA
Since 2018 · 11–20 empl.
The core activity of Probionova SA is the research and development of new probiotic strains and applications for therapeutic purposes, particularly in the field of human health and microbiome. The company develops clinically evidence-based probiotics with pharmaceutical quality for therapeutic applications and offers services such as the selection and development of probiotic strains, the manufacture of probiotic combinations, and the provision of full-service solutions.
VRFD SA
Since 2020 · 1–10 empl.
VRFD SA is the owner of the VERDILAB brand and develops and sells 100% natural skincare products formulated around a Signature Complex based on natural RNA. The range includes serums, creams, masks and complementary dermo-protocols, and the website refers to clinical-study support for product effectiveness.
KOLINPHARMA SUISSE SA
Since 2021 · 1–10 empl.
KOLINPHARMA SUISSE SA is a company that develops, manufactures and markets nutraceutical health products and dietary supplements. Its product range includes lines for neurological, uro‑gynecological, musculoskeletal and immune support.
KeyBioscience SA
Since 2012 · 11–20 empl.
KeyBioscience SA is a biotechnology company focused on the discovery and development of fully human monoclonal antibodies for the prevention and treatment of serious bacterial and viral infections in the hospital setting. It applies the MabIgX® technology to generate and select fully human monoclonal antibodies and is developing candidates such as KBRV201 targeting respiratory syncytial virus (RSV).
Probiotical Swiss SA
Since 2013 · 1–10 empl.
ROSE PHARMA SA
Since 2007 · 101–500 empl.3.0(2)
The core activity of Rose Pharma is the development, manufacture and distribution of hyaluronic acid-based fillers for aesthetic medicine, particularly for facial rejuvenation, skin rehydration, gynaecological rejuvenation and the treatment of joint diseases.
TILAB SWISS Sagl
Since 2020 · 11–20 empl.
The company is primarily active in the manufacture of pharmaceutical products, dietary supplements and cosmetics. It offers a wide range of products, including magistral and official galenic preparations, capsules, ointments, emulsions, liquids, gels and other pharmaceutical forms. The company has a laboratory certified to ISO:9001 and equipped with state-of-the-art technologies and analytical instruments to perform qualitative and quantitative analyses. The company's core activity includes the development, manufacture and marketing of products for health, skin and personal care.
Contrad Swiss SA
Since 2011 · 11–20 empl.4.7(3)
The core activity of Contrad Swiss is the development, manufacture and marketing of pharmaceutical products and medical devices, particularly in the area of self-medication (OTC) and regenerative aesthetics, with a focus on improving the health and quality of life of consumers and patients.
Vivendo Pharma GmbH
Since 2020 · 1–10 empl.
The core activity of Vivendo Pharma is the development, manufacture and marketing of pharmaceutical products, particularly in the field of biotechnology, as well as medical devices and devices with artificial intelligence. The company focuses on specific therapeutic areas such as ophthalmology, osteoarthritis and wound care, and offers products such as hyaluronic acid and bioactive colostrum. Vivendo Pharma works closely with international distributors to market its products worldwide.
OmniCap GmbH
Since 2011 · 11–20 empl.5.0(3)
The company is an international wholesaler and service provider for the pharmaceutical, cosmetics and food industries. The core activity consists of sourcing, storing and distributing products such as active ingredients, excipients and other chemicals for these industries. In addition, the company offers consulting and support services for companies in these sectors, including logistics, customs clearance and regulatory support.
Healiva SA
Since 2020 · 1–10 empl.
Healiva SA is a patient‑centric biotech company developing personalized therapies for chronic wound care. It combines cell therapies, enzyme technology and medical devices and is developing products such as EpiDex (epidermal cell graft), AQUAtryp (enzymatic debriding agent), Healiva 002 (allogeneic cell spray) and Healiva 004 (autologous blood patch) for hard‑to‑heal wounds.
InkVivo Technologies SA
Since 2023 · 11–20 empl.
The core activity of InkVivo Technologies AG is the development and manufacture of innovative drug and nutritional supplement release systems, which are produced using additive manufacturing (3D printing) and a scalable platform technology. These systems enable targeted, local and prolonged release of active ingredients, nutritional supplements and cells. The company focuses on revolutionizing drug delivery and release in the body.
In Virtuo Laboratories SA
Since 2024 · 1–10 empl.
In Virtuo Laboratories SA develops a platform that combines artificial intelligence and physics-based molecular simulations to identify and optimize drug candidates.
EXERIS BIO SA
Since 2023 · 1–10 empl.
EXERIS BIO SA provides custom solutions for the manufacturing of small molecules and recombinant proteins. The company also operates as a sales agency and chemical distributor representing custom chemical manufacturers.
DEVINTEC Sagl
Since 2017 · 1–10 empl.5.0(1)
The core activity of Devintec Pharma is the research and development of medical devices and dietary supplements, particularly the development of substance-based medical devices (SMD) using the patented DevinPro technology. This technology enables the creation of a protective, mucus-like barrier that restores the natural and physiological epithelial permeability and allows for the treatment of various diseases. The main therapeutic areas are gastroenterology, dermatology, and gynecology.
Crystal Hemp SA
Since 2016 · 11–20 empl.5.0(1)
The core activity of Crystal Hemp SA is the development, manufacture and marketing of products based on cannabinoids, in particular CBD products, as well as research and development of medical applications for cannabinoids, including clinical trials.
Advitech Consulting SA
Since 2024 · 1–10 empl.
Advitech Consulting SA is a boutique advisory firm focused on the healthcare and fine chemical industries, providing corporate business development, management consulting and business intelligence services, and product & technologies portfolio management.
Bio API SA
Since 2010 · 1–10 empl.
Viva SA
Since 1942 · 1–10 empl.
Siphar SA
Since 1963 · 1–10 empl.
Nutro SA
Since 1972 · 1–10 empl.
FARMACEUTICA TEOFARMA SUISSE SA
Since 2005 · 1–10 empl.
Quolibet SA
Since 2005 · 1–10 empl.
EAS Tibia Swiss SA
Since 2006 · 1–10 empl.
Novintethical Pharma SA
Since 2009 · 1–10 empl.
Lab Dom (Suisse) SA
Since 2010 · 1–10 empl.
SWC SWiSS WELLNESS CENTER SA
Since 2011 · 1–10 empl.
Fermentazione Microbiologica AG
Since 2012 · 1–10 empl.
HOLOS PHARM Sagl
Since 2012 · 1–10 empl.
FitoAMico SA
Since 2012 · 1–10 empl.
Genecta Pharmaceuticals Sagl
Since 2013 · 1–10 empl.
IM-TT INTERNATIONAL MEDI-TECH TRADE SA
Since 2013 · 1–10 empl.
Cuoralia Therapeutics Sagl
Since 2013 · 1–10 empl.
Pharmaceutical Industry in Lugano
Pharmaceutical Industry in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of October 10, 2026
Pharmaceutical Industry in other places
By canton